Cambridge’s Seaside at Forefront of new approach to Fragile X

Published August 23, 2010 in The Boston Globe

The story of Matthew, a 9-year-old with Fragile X Syndrome, is one of the first patients on one of the first medications ever developed specifically to address the causes of an autism-like disorder. And at least for him it seems to be working.

http://www.boston.com/business/healthcare/articles/2010/08/23/cambridges_seaside_has_new_approach_to_fragile_x/

Filed under: , ,